Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,977 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,375
Recruiting: 744
Ph III recruiting: 79
Growth YoY: +22.9%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.1%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06751524	Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval	available	—	—	Agenus Inc.INDUSTRY	0	May 15, 2026	clinicaltrials
NCT06836648	Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer	available	—	—	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Feb 25, 2026